Provided by Tiger Trade Technology Pte. Ltd.

Evoke Pharma

11.00
0.0000
Volume:- -
Turnover:517.64K
Market Cap:18.95M
PE:-5.42
High:11.00
Open:11.00
Low:11.00
Close:11.00
52wk High:11.00
52wk Low:1.94
Shares:1.72M
Float Shares:871.70K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0307
EPS(LYR):-2.8094
ROE:-134.88%
ROA:-21.78%
PB:5.64
PE(LYR):-3.92

Loading ...

Feb 07, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 05, 2024

Correspondence

Form CORRESP - Correspondence
Jan 05, 2024

Correspondence

Form CORRESP - Correspondence
Jan 04, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 19, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 15, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Major Issues Report

Form 8-K - Current report